Plate Nº 72 · recorded October 2, 2026
Health & Medicine ResearchReported finding
Screening Children for Type 1 Diabetes Is Feasible, 8-Country Study Finds
Pilot programs in eight European countries show children can be screened for type 1 diabetes, and researchers now propose testing at ages 2–4, 6–8 and 10–15.
By Elena Vasquez3 min read532 words
In brief
- Research presented at the EASD annual meeting in Milan (Sept. 28–Oct. 2) covers pilot screening programs in eight European countries.
- The authors, including Dr. Peter Achenbach and Prof. Anette-Gabriele Ziegler of Helmholtz Munich, say screening should be rolled out across Europe.
- They recommend three testing windows: ages 2–4, 6–8 and 10–15.
Pilot programs across eight European countries have shown that screening children for type 1 diabetes can work in practice, according to new research presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held in Milan, Italy, from September 28 to October 2.
The study's authors, a consortium that includes Dr. Peter Achenbach and Professor Anette-Gabriele Ziegler of the Institute of Diabetes Research at Helmholtz Munich in Germany, argue that the next step is clear: screening should be rolled out across Europe.
They propose an organized schedule with three testing windows — ages 2–4, 6–8, and 10–15 — rather than a single one-off test. Staggering the screenings this way would allow health systems to catch children who develop the biological warning signs of the disease at different points in their childhood.
Type 1 diabetes is an autoimmune condition in which the body's immune system attacks the insulin-producing cells of the pancreas. Insulin is the hormone that regulates blood sugar; without it, glucose builds up in the blood to dangerous levels. The disease often announces itself suddenly, sometimes with severe symptoms, before a family even knows something is wrong.
That is the problem screening aims to solve. The rationale behind the pilot programs is that the biological process leading to type 1 diabetes typically begins long before symptoms appear. Detecting that process early — through tests that identify markers of the disease in children who still feel perfectly healthy — gives families and doctors time to prepare, monitor, and intervene before a medical crisis strikes.
The new research, presented in Milan, reports on how these pilot screening programs performed in eight countries. The consortium's central conclusion is about feasibility: the pilots demonstrate that large-scale screening of children for type 1 diabetes can actually be organized and carried out within European healthcare systems, not merely discussed as an idea.
On the strength of those results, the authors are now calling for screening to become standard practice across the continent. Their recommended three-window schedule — early childhood (2–4), mid-childhood (6–8), and adolescence (10–15) — is designed to balance thoroughness with practicality for national health services.
The proposal remains, for now, a recommendation from researchers rather than an adopted policy. Scaling from pilot programs to continent-wide screening would require decisions by governments and health authorities in each country, and the data presented at a scientific meeting have not yet gone through the full scrutiny that follows formal publication in a peer-reviewed journal.
Still, the direction the consortium points toward is significant. If Europe-wide screening were adopted, children across the eight study countries — and potentially beyond — could routinely be tested for the early markers of type 1 diabetes at three points in their childhood, in much the same way they are already checked for other conditions as part of routine pediatric care.
The findings add to a growing conversation in European medicine about shifting from reacting to type 1 diabetes toward anticipating it. Whether that shift happens, and how quickly, will depend on how policymakers weigh the pilot data presented in Milan against the costs and logistics of universal screening.
via Medical Xpress (Source)
More from Elena Vasquez
Nearby plates
- No Clear Link Between Rotavirus Vaccination and Type 1 Diabetes
- Maurius Becomes First Country to Reverse Its Type 2 Diabetes Epidemic
- Very Low Carb Diets Show Health Benefits in Children with Type 1 Diabetes
- GLP-1 Diabetes Drugs Show Real-World Benefits in Young People
- Diet and Exercise Reverse Early-Onset Type 2 Diabetes in Half of Cases